 |
- Real-world outcomes: How AI improved both diagnostic efficiency, early detection, and comorbidity detection
- Deep dive into the precision technology of the FDA-cleared platform, AVIEW LCS Plus
PHILADELPHIA and SEOUL, South Korea, July 7, 2025 /PRNewswire/ — Coreline Soft, a leading provider of AI-based medical imaging solutions, announced it will co-host a strategic webinar with the renowned Temple Lung Center on August 1 at 1:30 PM EST, focused on AI-powered lung cancer screening and the evolving paradigm of early detection of chest disease.
Titled “AI in Action: How the Temple Lung Center Is Advancing Lung Screening and Patient Outcomes,” the webinar will feature Temple’s leading pulmonary expert, Dr. Gerard Criner. He will share how AI has been successfully integrated into hospital operations—supporting diagnostic accuracy and improving patient outcomes.
At the center of this initiative is Coreline‘s FDA-cleared AVIEW LCS Plus, a 3-in-1 solution capable of detecting lung nodules, quantifying emphysema, and analyzing coronary artery calcification—all from a single low-dose CT scan. Temple Health’s adoption of this platform has allowed them to streamline clinical workflows from detection to follow-up, delivering measurable improvements in care and ROI.
This session goes beyond technical demonstration. It offers firsthand insight into how AI is reshaping clinical decision-making, optimizing resource allocation, and enhancing both patient outcomes and experience. Temple Health, a nationally recognized institution in the U.S. Northeast, is drawing attention as a model for integrating AI beyond diagnosis—transforming it into a scalable, patient-centered care strategy.
“Our goal has always been to bring the most advanced tools to where they matter most—real patients, real decisions.
AI like Coreline‘s is not replacing clinical judgment, but reinforcing it—enhancing our ability to detect, triage, and treat lung disease earlier and more efficiently.”
— Dr. Gerard Criner, Temple Lung Center
The webinar is free to attend and open to pulmonologists, radiologists, cardiologists, respiratory adjacent professionals, hospital stakeholders and administrators and primary care providers across the U.S. and Canada. Interested participants can register for free in advance via the official registration link.
